JTO & JTO CRR
@JTOonline
Followers
5K
Following
468
Media
664
Statuses
4K
JTO & JTO CRR are the official journals of @IASLC & the source for information on detection, prevention, diagnosis & treatment of thoracic cancers. https://t.co/NE8oQDHwUx
New York, USA
Joined September 2010
🗞️Big results from Manchester #lungcancer #screening 🫁 It's difficult to measure how much real impact a programme has on the whole population, but we had the opportunity to study this in a region where screening has been offered since 2019 @JTOonline
https://t.co/GjHmNUhpok
jto.org
Low dose CT (LDCT) screening reduces lung cancer mortality in clinical trials, but evidence of impact in real-world programmes is lacking. Here we examine the impact of screening in a socio-economi...
1
2
4
The new prospective analysis from Schrump et al. sets a new paradigm for evaluating people with BCS, supporting efforts to ID & validate epigenetic #biomarkers for early detection and surveillance of #mesothelioma and other #cancers. https://t.co/TF21gN7WzV
0
0
1
SHEIN’s on-demand model leverages real-time data to create what customers want, reducing overproduction and waste while improving efficiency in fashion.
20
40
264
New findings from Cho et al. : TP53 and BRCA2 germline pathogenic variants and the ALKBH2 novel variant are associated with early-onset lung adenocarcinoma in Asian individuals. Read more in this month's JTO: https://t.co/BMc5WGJENN
0
3
7
Congratulations to Dr. Andrea Sboner (@asbonerw) from @WCMCPathology and the @WCMEnglanderIPM, and colleagues, on his new paper, "Longitudinal #genomic analysis of five cases of recurrent #thymomas," published in The Journal of Thoracic Oncology (@JTOonline) on November 18th!
0
1
10
The @IASLC MCSC & ART has just published the practical approach for unresctable LA-NSCLC in @JTOonline！ We provides 5 cases representing challenging scenarios for multidisciplinary discussion, inspiring best care for thoracic tumor boards. Read more 👉 https://t.co/sW0BThq5AK
1
6
14
Carbone et al. showed that mesothelioma in patients with the BAP1+/- mutation is biologically, histologically, and clinically distinct, requiring a tailored treatment approach. Read more in this month's JTO: https://t.co/0DvkblDcnN
0
16
23
Nice to see this online from @KCArbourMD @JessieStuart316 and colleagues. Shows overlap of MTAP deletions and EGFR mutations. Both at baseline and resistance. Example of potential approach to treatment. @IASLC @JTOonline @MSKCancerCenter
https://t.co/hSLn9dKgaq
2
7
23
The cancer center’s Misty D. Shields, MD, PhD, and colleagues share new insights in the Journal of Thoracic Oncology. Learn more: https://t.co/63GtbBpVOK.
#ResearchCuresCancer #NCIcomprehensive @JTOonline
0
1
3
Are germline variants (GPVs) risk factors for early-onset lung cancer? @JTOonline - GPVs identified in 350 early (<40yr) & 1441 late-onset (≥41yr) cases - GPVs in p53, BRCA1, BRCA2, ALKBH2 (DNA repair gene) = ⬆️ lung adeno risk @OncoAlert #LCSM
https://t.co/CdUbSL6yY3
jto.org
Up to 54% of all lung adenocarcinoma (LADC) cases in Asian populations occur in never-smoking women, suggesting that the impact of smoking and other environmental factors on the risk of early-onset...
2
18
51
🆕Just published🆕 #LCAM25 Editorial from #JTO Editor-in-Chief @DrAlexAdjei: "Lung Cancer in 2025: Advances in Treatment Continue, but Access Remains Unequal" 🔗 Read the full article here: https://t.co/ma0foXVgm8
@IASLC @JTOonline @ElsevierConnect #LCSM
1
6
15
👩🍼💖 In Journal of Thoracic Oncology, Prof. Lu You’s #WCH team reports the world’s first case of a woman with advanced ALK+ NSCLC on lorlatinib delivering a healthy baby 🎉 Multidisciplinary care balanced tumor control & motherhood dreams 🌍 #LungCancer #Oncology #CancerResearch
0
0
0
Low-dose lorlatinib during pregnancy: Yao et al. report a rare, successful case, underscoring potential safety and ongoing concerns. https://t.co/ayAdsu4NKx
@IHuaXil
1
6
11
Leighl et al. report that lenvatinib + pembrolizumab did not improve outcomes vs docetaxel in stage IV NSCLC after anti–PD-1/PD-L1 therapy and platinum chemo. More effective options are needed. https://t.co/NloTwNOAJN
https://t.co/NloTwNOAJN
1
3
15
How far has lung cancer care come in 50 years? The IASLC Communications Committee’s new “survival guide” article traces key advances and today’s standards. https://t.co/We0IRqit18
0
6
16
.@IASLC’s BaTS Committee review spotlights key advances in NSCLC research and outlines future areas that could improve survival and lead to new curative options for advanced disease. https://t.co/fHr7JKEbWY
0
3
7
📢 A new study in @JTOonline recommends a new grading system for invasive squamous cell carcinoma, aiming to improve prognostic accuracy and guide treatment decisions. Read more: https://t.co/ykR3YKPiTq
#LungCancer #ThoracicOncology #CancerResearch
iaslc.org
(Denver, Colo—October 7, 2025) Invasive lung squamous cell carcinoma (LUSC) accounts for approximately one-quarter of all lung cancers, but therapeutic optio ...
0
2
8
Inching toward a potential new standard of care, Bang et al. found that perioperative pembrolizumab demonstrated promising rates of major pathologic response, R0 resection, and long-term disease-free survival in stage III to IV TETs. https://t.co/lzEZyTVAO5
#ESMO25 @myESMO
0
0
3
A new publication from members of the Cancer Education team is out in the Journal of Thoracic Oncology (@JTOonline), exploring the inclusion of tobacco control and smoking-related content in major oncology meetings. Read it here:
jtocrr.org
Despite the importance of smoking cessation in cancer care, it remains unclear how much tobacco control and smoking-related content (TCSCR) is included in major oncology meetings. Developing an...
0
1
4
.@IASLC has created a comprehensive summary of how some of the major questions in lung cancer were addressed during the last 50 years: from prevention to staging, screening, diagnostics, therapeutics, and supportive care. Access their #NSCLC resource ▶️ https://t.co/Y5yoRGCl2T
1
4
6
New @IASLC data show smoking affects #lungcancer survival even within each stage. People who currently or formerly smoked often had outcomes similar to never-smokers in the next higher stage. Smoking may now be considered in the 10th TNM staging system. https://t.co/DSL6Awk9KW
1
9
19